Clinical Trials Directory

Trials / Completed

CompletedNCT01846260

Predictive Value of the Distress Thermometer as a Predictive Screening Instrument to Detect Cancer-related Cognitive Impairment in Cancer Patients

Status
Completed
Phase
Study type
Observational
Enrollment
125 (actual)
Sponsor
General Hospital Groeninge · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cognitive impairment associated with chemotherapy is an important reported post-treatment side-effect among breast and other cancer survivors. As some patients report cognitive complaints before the administration of their therapy, some authors suggest an association with psychological risk factors such as distress. Distress, a multifactorial unpleasant emotional experience of a psychological (cognitive, behavioral and emotional), social and/or spiritual nature that may interfere with the ability to cope with cancer effectively, its physical symptoms and its treatment, can easily be assessed by the Distress Thermometer. In this trial we aim to determine if the Distress Thermometer, accompanied by the 38-item Problem List, could predict cancer-related cognitive impairment in patients with hematologic malignancies, and in patients with gynecological, urological, breast, lung or gastro-intestinal cancer receiving curative radiotherapy, chemotherapy, radiochemotherapy, anti-hormonal or targeted therapy.

Detailed description

Design: Prospective, observational study. All cancer patients of the above mentioned cancer types receiving an anticancer treatment with curative intent will be asked to participate to this study. Consenting patients will undergo serial assessment at baseline, and 6 months after inclusion. Patient will be screened by the Distress Thermometer and 38-item Problem List followed by a neuropsychological assessment and self-assessment tools.

Conditions

Timeline

Start date
2013-04-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2013-05-03
Last updated
2018-02-15

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01846260. Inclusion in this directory is not an endorsement.

Predictive Value of the Distress Thermometer as a Predictive Screening Instrument to Detect Cancer-related Cognitive Imp (NCT01846260) · Clinical Trials Directory